| Similar Articles |
|---|
 |
The Motley Fool
March 16, 2007
Tom Taulli |
CBOT Gets an ICE Pick IntercontinentalExchange makes a last-minute bid for the Chicago Board of Trade. This is complex stuff, and not a safe place for smart investors. Keep your money to yourself, but pull up a chair and watch. This should be a pretty good fight.   |
The Motley Fool
December 19, 2006
Matthew Crews |
Express Scripts' Takeover Battle The pharmacy benefits manager challenges CVS with a higher bid for rival Caremark RX. Investors, stay tuned -- this is far from over. |
The Motley Fool
July 25, 2011
Brian Orelli |
Express-Medco: Just What the Doctor Prescribed In perhaps the most obviously beneficial merger ever, Express Scripts announced its plan to buy Medco Health Solutions for $29.1 billion. |
The Motley Fool
January 8, 2007
Matthew Crews |
CVS' Tightrope Walk The drugstore chain's aggressive growth strategy continues to pay off -- for now. Investors, take note. |
The Motley Fool
April 19, 2007
S.J. Caplan |
CBOT Sitting Pretty The Chicago Board of Trade's parent posts impressive first-quarter earnings. Investors, take note. |
The Motley Fool
November 2, 2006
Ryan Fuhrmann |
CVS Blazes a New Healthcare Trail Strong third-quarter earnings aside, the merger announcement with pharmacy benefit manager Caremark was the real shocker here. Investors, take note. |
The Motley Fool
August 1, 2007
Ryan Fuhrmann |
Foolish Forecast: CVS Caremark Gets Ready to Rumble CVS Caremark will announce its first combined quarterly results tomorrow. Competitors will be watching to see if the merger of drugstore chain and pharmacy benefit manager is a healthy one. |
The Motley Fool
April 25, 2007
Matt Koppenheffer |
Chicago Merc Makes Its Mark If we invested in a price-free vacuum, this quarter would be great news for Chicago Merc investors. Unfortunately, that's not the case. |
The Motley Fool
May 8, 2007
Ryan Fuhrmann |
CVS/Caremark Tie the Knot While it's too early to see if CVS blazed a new health-care trail by combining a drugstore chain with giant pharmacy benefit manager Caremark, there are still interesting tidbits to pass along to investors from recently reported results. |
The Motley Fool
July 25, 2007
John Finneran |
New CME Dominates Derivatives CME Group, the new exchange formed from the merger of the Chicago Mercantile Market and the Chicago Board of Trade, enjoys the benefits of an 85% market share. |
The Motley Fool
June 29, 2005
Stephen D. Simpson |
Love in the Pits? Rumors say the Chicago Merc wants to buy the Chicago Board of Trade before CBOT goes public. Meanwhile, the Merc has tacked on almost $50 in stock value in the past two days, a 19% rise. |
The Motley Fool
August 3, 2007
Ryan Fuhrmann |
CVS Caremark Is No Sicko Pharmacy powerhouse CVS Caremark is looking to blaze a new health-care trail with the recent merger of their drugstore and pharmacy benefit management operations. |
The Motley Fool
March 6, 2009
Brian Orelli |
Don't Let It Go! Health insurer WellPoint is trying to sell its pharmacy business management segment. Is it the right move for them for right now? |
The Motley Fool
April 13, 2009
Brian Orelli |
Prescriptions for Acquisitions Express Scripts announces that it is buying WellPoint's NextRx pharmaceutical benefit management subsidiaries for almost $4.7 billion. |
CFO
March 1, 2012
David McCann |
Companies May Win This Drug War The conflict between Express Scripts and Walgreen just might lead to lower drug-benefit costs for companies. |
The Motley Fool
March 26, 2010
Cathy Applefeld Olson |
Can CVS Caremark Win the Drug Wars? Now that health-care legislation has been signed into law, it's a perfect time to give the country's largest drugstore chain a checkup. |
The Motley Fool
October 18, 2006
Stephen Ellis |
Chicago Merc: What Took You So Long? The deal that was obvious to everyone is finally done. The Chicago Mercantile Exchange Holdings announced that it will merge with the Chicago Board of Trade to form the CME Group, with a combined value of $25 billion. Investors, take note. |
The Motley Fool
February 2, 2007
Ryan Fuhrmann |
Uncertain Outlook on CVS Has the retail pharmacy bit off more than it can chew? Investors may soon look back longingly to the day when CVS focused as much on organic, or internal, means to grow its business as it does on acquisitions to buy outside market share. |
The Motley Fool
June 30, 2011
David Williamson |
Pharmacy Benefits Delivering Drama CVS claims another Medco client and one messy split. |
The Motley Fool
April 9, 2007
Mike Cianciolo |
CVS: Continued Vigorous Sales The drugstore chain grows sales and itself in March. Investors, take note. |
BusinessWeek
April 9, 2007
Gene G. Marcial |
Hail To CVS/Caremark Deal or no deal, CVS was already a fave on Wall Street. And now that it has acquired Caremark Rx, No.2 in pharmacy-benefits management, Goldman Sachs, UBS, and Matrix USA are even more bullish. |
The Motley Fool
October 8, 2011
Shubh Datta |
Impasse Hurts Walgreen's Quarter Walgreen posted a staggering 69% earnings jump but still saw its shares slide. |
The Motley Fool
October 2, 2011
Shubh Datta |
Would You Invest in This Drug Retailer? Is CVS Caremark worth your investment? |
The Motley Fool
June 18, 2007
S.J. Caplan |
There WILL Be a Quiz: Weekly Markets Recap A strong boost to equities could have jolted Dad off the couch. Have you been paying attention? Find out with our capital markets roundup and investors' quiz. |
The Motley Fool
November 10, 2006
Dan Caplinger |
Profit From Arbitrage Sometimes you don't have to hit a home run to make money in the markets. |
The Motley Fool
August 31, 2011
Shubh Datta |
CVS Caremark Flattened by Higher Costs CVS Caremark profits remained relatively flat this quarter despite a substantial increase in revenue. |
The Motley Fool
November 5, 2007
Timothy M. Otte |
CVS Is in the Zone Pharmacy giant CVS grew EPS by 36% in the third quarter. The company has been on a roll since its merger with Caremark last year. |
CFO
January 10, 2007
Roy Harris |
The Year of Living Strategically While private-equity bids got lots of attention, some public-company mergers aimed to remake their industries in 2006. |
The Motley Fool
June 10, 2010
Claire Stephanic |
CVS Caremark vs. Walgreen The two go head-to-head in competition for pharmacy customers. |
The Motley Fool
July 21, 2006
Alex Dumortier |
Killer 'BOT Crushes Its Quarter The Chicago Board of Trade's parent company reported earnings reflecting the power of the tollkeeper business model. Investors, take note. |
The Motley Fool
March 22, 2010
Dave Mock |
A Big Upgrade for CVS Caremark This bullish call comes from more than just one analyst. |
The Motley Fool
October 6, 2011
Dan Caplinger |
Has Medco Health Solutions Become the Perfect Stock? A lot has happened in the pharmacy benefits management space since we looked at Medco last year. |
InternetNews
March 16, 2007
Clint Boulton |
Cisco to Microsoft: Put Up Your Dukes Cisco defends its unified communications turf with what one analyst described as a 'Google move.' |
The Motley Fool
November 30, 2006
John Finneran |
Are Exchanges Overheated? Stock exchanges' stratospheric valuations may not reflect reality. |
Wall Street & Technology
December 18, 2007
Ivy Schmerken |
CME Group Migrates Combined CME-CBOT Electronic Trading to a Single Platform CME Group is migrating all the CBOT products to the CME Globex electronic trading platform while consolidating two open-outcry trading floors into one. |
The Motley Fool
May 30, 2011
Andrew Tonner |
Does UnitedHealth Group Deserve a Spot in Your Portfolio? Although UnitedHealth Group could look like a stock for your portfolio right now, the search doesn't end here. |
The Motley Fool
October 29, 2009
Brian Orelli |
Expressing Itself Nicely A nice quarter for Express Scripts. |
The Motley Fool
February 15, 2006
Stephen D. Simpson |
Good Marks for Caremark The pharmacy benefits management company should have even more positive operating leverage left in the tank. Investors, take note. |
BusinessWeek
May 9, 2005
Weintraub & Barrett |
BW 50: Can Caremark's Health Hold Up? Caremark Rx Inc. faces a growing set of legal and market challenges, but Its drug-benefit business is soaring, and its CEO remains upbeat about the future. |
The Motley Fool
October 26, 2006
Stephen Ellis |
ISE: Another Red-Hot Exchange The International Securities Exchange continues a winning streak as it rides the options wave. Investors, take note. |
InternetNews
March 15, 2007
Clint Boulton |
Cisco Bids $3.2B For WebEx Cisco sees WebEx as a key part of its online collaboration strategy for SMBs. |
The Motley Fool
May 2, 2008
Timothy M. Otte |
CVS Caremark and the Snickers Factor The soft economy has hit some retail sectors hard. But there are still pockets of life, and CVS Caremark is one of the companies leading the way. |
The Motley Fool
February 1, 2007
Ryan Fuhrmann |
Busy Aisles at CVS: Fool by Numbers The drugstore retailer released fourth-quarter and 2006 year-end results: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
August 24, 2010
David Meier |
Can Express Scripts Produce Big Returns? Express Scripts generates incredible returns on equity. Let's see how they do it. |
The Motley Fool
July 9, 2007
S.J. Caplan |
There WILL Be a Quiz: Weekly Markets Recap Takeover news was front and center during the shortened trading week. Have you been paying attention? Find out with our capital markets roundup and investors' quiz. |
The Motley Fool
January 3, 2012
Shubh Datta |
Things Aren't Looking Great For Walgreen Walgreen net income slips due to a meek flu season and its breakup with Express Scripts. |
The Motley Fool
November 8, 2006
Michael P. Cecil |
CVS/Caremark: A Brobdingnagian Drug Seller The merger of CVS and Caremark says a lot about pharmaceutical retailers and pharmacy benefit mangers trying to deal with a rapidly changing paradigm. |
The Motley Fool
December 29, 2006
John Finneran |
Previewing 2007: NYSE Group Given the zoom in exchange stocks this year, valuing NYSE relative to other exchange stocks requires caution -- they are all very high. |
The Motley Fool
May 4, 2011
Jason Knapp |
Generic Drugs and Old People Could Make You Rich CVS hasn't generated market-beating returns yet -- but it will. |
The Motley Fool
November 22, 2006
Joseph Khattab |
Exchange Stocks Still Smokin' A recap of some of the hottest stocks on the market. April 2005 -- NYSE upgrades... March 2006 -- Nasdaq raises the stakes... March 2006 -- AMEX joins the party... etc. |
